Deep vein thrombosis in the patient with cancer.
The association between thromboembolic disease and cancer has long been recognized. Armand Trousseau first brought this association to the attention of the medical profession in 1868 (Haire, 2000). Oncology nurses need to be knowledgeable about preventive measures, early signs and symptoms of thromboembolic disease, and complications of therapy.
Dell
Deena Damsky
DD
Fox Chase Cancer Center,  Philadelphia, PA, USA. d_dell@fccc.edu
D000368:Aged; D001943:Breast Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007262:Infusions, Intravenous; D018570:Risk Assessment; D012720:Severity of Illness Index; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control*; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing*
D006493:Heparin